nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—SLC7A8—tongue—salivary gland cancer	0.0533	0.147	CbGeAlD
L-DOPA—PSIP1—neck—salivary gland cancer	0.0465	0.128	CbGeAlD
L-DOPA—SLC7A8—neck—salivary gland cancer	0.0306	0.0844	CbGeAlD
L-DOPA—PSIP1—lymphoid tissue—salivary gland cancer	0.0243	0.0671	CbGeAlD
L-DOPA—SLC7A5—parotid gland—salivary gland cancer	0.0193	0.0533	CbGeAlD
L-DOPA—SLC7A5—saliva-secreting gland—salivary gland cancer	0.0185	0.051	CbGeAlD
L-DOPA—SLC16A10—neck—salivary gland cancer	0.0182	0.0501	CbGeAlD
L-DOPA—SLC7A5—connective tissue—salivary gland cancer	0.017	0.0469	CbGeAlD
L-DOPA—SLC7A5—epithelium—salivary gland cancer	0.0161	0.0445	CbGeAlD
L-DOPA—SLC16A10—parotid gland—salivary gland cancer	0.0148	0.0408	CbGeAlD
L-DOPA—PSIP1—lymph node—salivary gland cancer	0.0137	0.0379	CbGeAlD
L-DOPA—SLC15A1—epithelium—salivary gland cancer	0.0134	0.0369	CbGeAlD
L-DOPA—DRD5—lymphoid tissue—salivary gland cancer	0.0134	0.0368	CbGeAlD
L-DOPA—SLC7A5—lymphoid tissue—salivary gland cancer	0.0124	0.0343	CbGeAlD
L-DOPA—SLC16A10—epithelium—salivary gland cancer	0.0124	0.0341	CbGeAlD
L-DOPA—SLC16A10—lymphoid tissue—salivary gland cancer	0.00952	0.0262	CbGeAlD
L-DOPA—SLC7A8—lymph node—salivary gland cancer	0.00905	0.025	CbGeAlD
L-DOPA—DDC—lymph node—salivary gland cancer	0.00783	0.0216	CbGeAlD
L-DOPA—SLC7A5—lymph node—salivary gland cancer	0.00702	0.0193	CbGeAlD
L-DOPA—SLC16A10—lymph node—salivary gland cancer	0.00537	0.0148	CbGeAlD
L-DOPA—SLC16A10—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00265	0.00416	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—MC3R—salivary gland cancer	0.00264	0.00415	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—MC3R—salivary gland cancer	0.00261	0.00409	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00256	0.00401	CbGpPWpGaD
L-DOPA—PSIP1—Disease—DTX4—salivary gland cancer	0.00251	0.00394	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—MYB—salivary gland cancer	0.00247	0.00387	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—CRTC1—salivary gland cancer	0.00245	0.00384	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.0024	0.00377	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00233	0.00365	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00222	0.00349	CbGpPWpGaD
L-DOPA—DRD1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00216	0.0034	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00214	0.00335	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—MC3R—salivary gland cancer	0.00213	0.00334	CbGpPWpGaD
L-DOPA—PSIP1—Disease—FGF16—salivary gland cancer	0.00208	0.00326	CbGpPWpGaD
L-DOPA—SLC15A1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00206	0.00323	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00206	0.00323	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00203	0.00318	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—PRKDC—salivary gland cancer	0.002	0.00314	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—MC3R—salivary gland cancer	0.002	0.00313	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NUP62—salivary gland cancer	0.00199	0.00313	CbGpPWpGaD
L-DOPA—PSIP1—Disease—VCAN—salivary gland cancer	0.00198	0.0031	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00198	0.0031	CbGpPWpGaD
L-DOPA—SLC7A8—Cell surface interactions at the vascular wall—PIK3CA—salivary gland cancer	0.00194	0.00304	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00185	0.00291	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00183	0.00287	CbGpPWpGaD
L-DOPA—PSIP1—Disease—MAML2—salivary gland cancer	0.00181	0.00283	CbGpPWpGaD
L-DOPA—SLC7A8—Cell surface interactions at the vascular wall—HRAS—salivary gland cancer	0.00179	0.00281	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0017	0.00267	CbGpPWpGaD
L-DOPA—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—salivary gland cancer	0.00169	0.00265	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00169	0.00265	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00167	0.00261	CbGpPWpGaD
L-DOPA—DRD2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00163	0.00256	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ISYNA1—salivary gland cancer	0.00159	0.00249	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—MC3R—salivary gland cancer	0.00157	0.00246	CbGpPWpGaD
L-DOPA—SLC7A5—Cell surface interactions at the vascular wall—HRAS—salivary gland cancer	0.00156	0.00245	CbGpPWpGaD
L-DOPA—PSIP1—Disease—JAG1—salivary gland cancer	0.00154	0.00242	CbGpPWpGaD
L-DOPA—PSIP1—Disease—FGFR4—salivary gland cancer	0.00154	0.00241	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00152	0.00238	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00151	0.00237	CbGpPWpGaD
L-DOPA—PSIP1—Disease—FBXW7—salivary gland cancer	0.00151	0.00237	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—TOP2A—salivary gland cancer	0.0015	0.00235	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—MC3R—salivary gland cancer	0.00141	0.00222	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.0014	0.0022	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—MC3R—salivary gland cancer	0.00139	0.00219	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00135	0.00212	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00132	0.00207	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MARCKS—salivary gland cancer	0.00129	0.00203	CbGpPWpGaD
L-DOPA—PSIP1—Disease—FOXO3—salivary gland cancer	0.00127	0.002	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00123	0.00192	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PYGB—salivary gland cancer	0.0012	0.00189	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—MC3R—salivary gland cancer	0.0012	0.00188	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00115	0.0018	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00113	0.00178	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—MC3R—salivary gland cancer	0.00109	0.00171	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—MC3R—salivary gland cancer	0.00107	0.00167	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00105	0.00164	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—CREBBP—salivary gland cancer	0.00104	0.00163	CbGpPWpGaD
L-DOPA—PSIP1—Disease—MAP2K2—salivary gland cancer	0.00104	0.00163	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PHGDH—salivary gland cancer	0.00098	0.00154	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—PTEN—salivary gland cancer	0.000972	0.00152	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ST3GAL4—salivary gland cancer	0.000944	0.00148	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—EP300—salivary gland cancer	0.000927	0.00145	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—CREBBP—salivary gland cancer	0.000909	0.00143	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000905	0.00142	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000902	0.00141	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—MC3R—salivary gland cancer	0.000886	0.00139	CbGpPWpGaD
L-DOPA—DDC—Metabolism—AQP1—salivary gland cancer	0.000857	0.00135	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NOTCH1—salivary gland cancer	0.000852	0.00134	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—WNT5B—salivary gland cancer	0.000818	0.00128	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000815	0.00128	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—MC3R—salivary gland cancer	0.000805	0.00126	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000804	0.00126	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—MC3R—salivary gland cancer	0.000798	0.00125	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL17RD—salivary gland cancer	0.00079	0.00124	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—MC3R—salivary gland cancer	0.000787	0.00124	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000787	0.00123	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CREBBP—salivary gland cancer	0.000773	0.00121	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—MC3R—salivary gland cancer	0.000725	0.00114	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAML3—salivary gland cancer	0.000723	0.00113	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—MC3R—salivary gland cancer	0.000715	0.00112	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—EP300—salivary gland cancer	0.000709	0.00111	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NUP62—salivary gland cancer	0.00068	0.00107	CbGpPWpGaD
L-DOPA—DDC—Metabolism—VCAN—salivary gland cancer	0.000674	0.00106	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—TP53—salivary gland cancer	0.000663	0.00104	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MC3R—salivary gland cancer	0.000644	0.00101	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00062	0.000973	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—EP300—salivary gland cancer	0.000619	0.000971	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000615	0.000966	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—WNT5B—salivary gland cancer	0.000604	0.000948	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—MC3R—salivary gland cancer	0.000602	0.000945	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL17RD—salivary gland cancer	0.000583	0.000915	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—PTEN—salivary gland cancer	0.000563	0.000884	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DTX4—salivary gland cancer	0.000563	0.000884	CbGpPWpGaD
L-DOPA—PSIP1—Disease—PTEN—salivary gland cancer	0.000552	0.000866	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—MC3R—salivary gland cancer	0.000547	0.000859	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—WNT5B—salivary gland cancer	0.000544	0.000853	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—EP300—salivary gland cancer	0.000537	0.000843	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—WNT5B—salivary gland cancer	0.000536	0.000842	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAML3—salivary gland cancer	0.000533	0.000837	CbGpPWpGaD
L-DOPA—PSIP1—Disease—EP300—salivary gland cancer	0.000526	0.000826	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL17RD—salivary gland cancer	0.000525	0.000824	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—PIK3CA—salivary gland cancer	0.000525	0.000823	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000523	0.00082	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL17RD—salivary gland cancer	0.000518	0.000813	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—TP53—salivary gland cancer	0.000508	0.000797	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—PTEN—salivary gland cancer	0.000507	0.000796	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—PTEN—salivary gland cancer	0.0005	0.000785	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—HRAS—salivary gland cancer	0.000485	0.000762	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—EP300—salivary gland cancer	0.000484	0.000759	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAML3—salivary gland cancer	0.00048	0.000754	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—EP300—salivary gland cancer	0.000477	0.000749	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MC3R—salivary gland cancer	0.000475	0.000746	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAML3—salivary gland cancer	0.000474	0.000744	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FGF16—salivary gland cancer	0.000466	0.000731	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—PIK3CA—salivary gland cancer	0.000458	0.000719	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000458	0.000718	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—TP53—salivary gland cancer	0.000443	0.000695	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MC3R—salivary gland cancer	0.000428	0.000672	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—HRAS—salivary gland cancer	0.000424	0.000665	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MC3R—salivary gland cancer	0.000422	0.000663	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DTX4—salivary gland cancer	0.000416	0.000652	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000412	0.000647	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—WNT5B—salivary gland cancer	0.00041	0.000644	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000407	0.000638	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000406	0.000637	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAML2—salivary gland cancer	0.000405	0.000635	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL17RD—salivary gland cancer	0.000396	0.000622	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000395	0.000619	CbGpPWpGaD
L-DOPA—PSIP1—Disease—PIK3CA—salivary gland cancer	0.000389	0.000611	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—TP53—salivary gland cancer	0.000385	0.000604	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—PTEN—salivary gland cancer	0.000383	0.000601	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DTX4—salivary gland cancer	0.000374	0.000587	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DTX4—salivary gland cancer	0.000369	0.000579	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—EP300—salivary gland cancer	0.000365	0.000573	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000365	0.000573	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAML3—salivary gland cancer	0.000363	0.000569	CbGpPWpGaD
L-DOPA—PSIP1—Disease—HRAS—salivary gland cancer	0.00036	0.000565	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—TP53—salivary gland cancer	0.000346	0.000543	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—JAG1—salivary gland cancer	0.000345	0.000542	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FGFR4—salivary gland cancer	0.000344	0.00054	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGF16—salivary gland cancer	0.000344	0.00054	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—TP53—salivary gland cancer	0.000342	0.000536	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FBXW7—salivary gland cancer	0.000338	0.000531	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MC3R—salivary gland cancer	0.000323	0.000507	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000311	0.000488	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGF16—salivary gland cancer	0.000309	0.000486	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGF16—salivary gland cancer	0.000305	0.000479	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAML2—salivary gland cancer	0.000299	0.000469	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000297	0.000467	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000291	0.000457	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—FOXO3—salivary gland cancer	0.000285	0.000448	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DTX4—salivary gland cancer	0.000282	0.000443	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000277	0.000434	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAML2—salivary gland cancer	0.000269	0.000422	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAML2—salivary gland cancer	0.000265	0.000416	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CREBBP—salivary gland cancer	0.000264	0.000414	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000262	0.000411	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TP53—salivary gland cancer	0.000261	0.00041	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000259	0.000406	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—JAG1—salivary gland cancer	0.000255	0.0004	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGFR4—salivary gland cancer	0.000254	0.000398	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FBXW7—salivary gland cancer	0.00025	0.000392	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGF16—salivary gland cancer	0.000234	0.000367	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAP2K2—salivary gland cancer	0.000233	0.000366	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—JAG1—salivary gland cancer	0.00023	0.00036	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGFR4—salivary gland cancer	0.000229	0.000359	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—JAG1—salivary gland cancer	0.000226	0.000355	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGFR4—salivary gland cancer	0.000226	0.000354	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000225	0.000354	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FBXW7—salivary gland cancer	0.000225	0.000353	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FBXW7—salivary gland cancer	0.000222	0.000348	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000217	0.000341	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FOXO3—salivary gland cancer	0.000211	0.000331	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAML2—salivary gland cancer	0.000203	0.000319	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000198	0.000311	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000197	0.000309	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOTCH1—salivary gland cancer	0.000191	0.0003	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FOXO3—salivary gland cancer	0.00019	0.000298	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTEN—salivary gland cancer	0.000188	0.000295	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FOXO3—salivary gland cancer	0.000187	0.000294	CbGpPWpGaD
L-DOPA—DDC—Metabolism—EP300—salivary gland cancer	0.000179	0.000282	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—JAG1—salivary gland cancer	0.000173	0.000272	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CREBBP—salivary gland cancer	0.000173	0.000272	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGFR4—salivary gland cancer	0.000173	0.000271	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAP2K2—salivary gland cancer	0.000172	0.00027	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FBXW7—salivary gland cancer	0.00017	0.000266	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000163	0.000255	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000156	0.000245	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000155	0.000243	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000155	0.000243	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000153	0.00024	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000148	0.000232	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FOXO3—salivary gland cancer	0.000143	0.000225	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOTCH1—salivary gland cancer	0.000141	0.000221	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HRAS—salivary gland cancer	0.000137	0.000214	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PIK3CA—salivary gland cancer	0.000133	0.000208	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCND1—salivary gland cancer	0.000128	0.000201	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CREBBP—salivary gland cancer	0.000128	0.000201	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000127	0.000199	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000125	0.000196	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTEN—salivary gland cancer	0.000124	0.000194	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00012	0.000188	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—salivary gland cancer	0.000118	0.000185	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000117	0.000184	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CREBBP—salivary gland cancer	0.000115	0.000181	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CREBBP—salivary gland cancer	0.000114	0.000178	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000109	0.000171	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000108	0.00017	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000107	0.000167	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HRAS—salivary gland cancer	0.000101	0.000158	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	9.81e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PIK3CA—salivary gland cancer	9.68e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	9.58e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCND1—salivary gland cancer	9.46e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTEN—salivary gland cancer	9.13e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HRAS—salivary gland cancer	9.08e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HRAS—salivary gland cancer	8.96e-05	0.000141	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PIK3CA—salivary gland cancer	8.72e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—salivary gland cancer	8.7e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	8.69e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCND1—salivary gland cancer	8.51e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—salivary gland cancer	8.44e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCND1—salivary gland cancer	8.4e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTEN—salivary gland cancer	8.22e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.16e-05	0.000128	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTEN—salivary gland cancer	8.11e-05	0.000127	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HRAS—salivary gland cancer	8.07e-05	0.000127	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—salivary gland cancer	7.84e-05	0.000123	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—salivary gland cancer	7.73e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	7.41e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	6.85e-05	0.000108	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PIK3CA—salivary gland cancer	6.44e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCND1—salivary gland cancer	6.43e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—salivary gland cancer	6.23e-05	9.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTEN—salivary gland cancer	6.2e-05	9.74e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CREBBP—salivary gland cancer	6.06e-05	9.51e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HRAS—salivary gland cancer	5.96e-05	9.35e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—salivary gland cancer	5.92e-05	9.28e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PIK3CA—salivary gland cancer	5.8e-05	9.1e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PIK3CA—salivary gland cancer	5.72e-05	8.98e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—salivary gland cancer	5.61e-05	8.8e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—salivary gland cancer	5.53e-05	8.68e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HRAS—salivary gland cancer	5.36e-05	8.42e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HRAS—salivary gland cancer	5.29e-05	8.3e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	4.38e-05	6.87e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTEN—salivary gland cancer	4.33e-05	6.79e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—salivary gland cancer	4.23e-05	6.64e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—salivary gland cancer	4.13e-05	6.48e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HRAS—salivary gland cancer	4.05e-05	6.35e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	3.05e-05	4.79e-05	CbGpPWpGaD
